| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| UNII: | DR6P1M58PO |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Glucagon-like peptide 1 receptor agonist |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Non-alcoholic Fatty Liver Disease | 2 | D065626 | ClinicalTrials |
| Non-alcoholic Fatty Liver Disease | 2 | D065626 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | 1 | D003924 | ClinicalTrials |
| Kidney Failure, Chronic | 1 | D007676 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297576 |
| FDA SRS | DR6P1M58PO |
CONTENTS